For immediate release
Particle Measuring Systems
+1 (303) 443-7100
NEW MICROBIAL TESTING TECHNOLOGY FOR CLEANROOMS ANNOUNCED BY MOCON, PARTICLE MEASURING SYSTEMS
Minneapolis (February 3, 2016) – Cleanroom operators will now be able to detect the presence of extremely low levels of microbial cells on surfaces much faster than traditional solutions. The capability is a result of a global marketing agreement between MOCON, Inc. (NASDAQ: MOCO) and Particle Measuring Systems (PMS).
MOCON’s GreenLight® system has a proven track record in reliability, sensitivity and speed across applications in many industries. It requires a fraction of the time needed by traditional plate counting methods to achieve results. The agreement gives PMS exclusive rights to market GreenLight® technology to pharmaceutical companies worldwide.
To improve cleanroom testing, Particle Measuring Systems has developed the SurCapt™ Microbial Surface Detection Kit, using GreenLight® technology. This provides an all-inclusive, ready-to-use solution which simplifies and accelerates environmental surface testing for biological contamination. The design of the SurCapt kit reduces the likelihood of sample cross contamination and mishandling by the operator.
“By leveraging GreenLight® technology with our SurCapt™ Microbial Detection Kit, we are providing pharmaceutical companies the objective evidence they are currently missing in a timeframe that enables more effective decision-making. This breakthrough enhances quality assurance throughout the value chain,” said Giovanni Scialo, vice president, life sciences, Particle Measuring Systems.
About Particle Measuring Systems
Particle Measuring Systems, a Spectris company, provides life science and electronic companies with the contamination monitoring solutions needed for sterility assurance and yield loss protection. For more information visit www.pmeasuring.com
MOCON provides the world’s most comprehensive range of premium instruments and services in four business areas: permeation, package testing, industrial analyzers and microbial detection. MOCON also provides consulting and laboratory services. For more information visit www.mocon.com.
This press release contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include but are not limited to: uncertainties relating to competition and technological change, setbacks in product development program, slower-than-anticipated customer acceptance of new products, dependence on certain key industries, risk associated with the Company’s acquisition strategy and international operations, and other factors set forth in the Company’s filing with the Securities and Exchange Commission.